322 related articles for article (PubMed ID: 24574835)
41. Deployment of drug-eluting stents for isolated proximal lad disease is associated with lower major adverse cardiac events and no increase in stent thrombosis when compared with bare metal stents: a 5-year observational cohort study.
Jones DA; Rathod KS; Gallagher S; Weerackody R; Knight CJ; Rothman MT; Mathur A; Jain AK; Timmis AD; Wragg A
Catheter Cardiovasc Interv; 2013 May; 81(6):E237-44. PubMed ID: 22707383
[TBL] [Abstract][Full Text] [Related]
42. First results of the DEB-AMI (drug eluting balloon in acute ST-segment elevation myocardial infarction) trial: a multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in primary percutaneous coronary intervention with 6-month angiographic, intravascular, functional, and clinical outcomes.
Belkacemi A; Agostoni P; Nathoe HM; Voskuil M; Shao C; Van Belle E; Wildbergh T; Politi L; Doevendans PA; Sangiorgi GM; Stella PR
J Am Coll Cardiol; 2012 Jun; 59(25):2327-37. PubMed ID: 22503057
[TBL] [Abstract][Full Text] [Related]
43. The efficacy of everolimus-eluting stent implantation in patients with ST-segment elevation myocardial infarction: outcomes of 2-year clinical follow-up.
Yano H; Horinaka S; Ishikawa M; Ishimitsu T
Heart Vessels; 2016 Oct; 31(10):1609-15. PubMed ID: 26686370
[TBL] [Abstract][Full Text] [Related]
44. Long-Term Clinical Outcomes of Biodegradable-Polymer Drug-Eluting Stents Versus Second-Generation Durable-Polymer Drug-Eluting Stents for ST-Segment Elevation Myocardial Infarction.
Sim HW; Thong EH; Djohan AH; Chen JZ; Ser JS; Loh PH; Lee CH; Chan MY; Low AF; Tay EL; Chan KH; Tan HC; Loh JP
Cardiovasc Revasc Med; 2022 Feb; 35():98-103. PubMed ID: 33893053
[TBL] [Abstract][Full Text] [Related]
45. Long-term outcomes of drug-eluting versus bare-metal stent for ST-elevation myocardial infarction.
Wang L; Wang H; Dong P; Li Z; Wang Y; Duan N; Zhao Y; Wang S
Arq Bras Cardiol; 2014 Jun; 102(6):529-38. PubMed ID: 25004414
[TBL] [Abstract][Full Text] [Related]
46. Meta-analysis of long-term outcomes for drug-eluting stents versus bare-metal stents in primary percutaneous coronary interventions for ST-segment elevation myocardial infarction.
Wallace EL; Abdel-Latif A; Charnigo R; Moliterno DJ; Brodie B; Matnani R; Ziada KM
Am J Cardiol; 2012 Apr; 109(7):932-40. PubMed ID: 22221949
[TBL] [Abstract][Full Text] [Related]
47. Clinical outcome after surgical or percutaneous revascularization in coronary bypass graft failure.
Harskamp RE; Beijk MA; Damman P; Kuijt WJ; Woudstra P; Grundeken MJ; Kloek JJ; Tijssen JG; de Mol BA; de Winter RJ
J Cardiovasc Med (Hagerstown); 2013 Jun; 14(6):438-45. PubMed ID: 22828774
[TBL] [Abstract][Full Text] [Related]
48. [Efficacy comparison of primary percutaneous coronary intervention by drug-coated balloon angioplasty or drug-eluting stenting in acute myocardial infarction patients with de novo coronary lesions].
Zhang DP; Wang LF; Liu Y; Li KB; Xu L; Li WM; Ni ZH; Xia K; Zhang ZY; Yang XC
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):600-607. PubMed ID: 32842271
[No Abstract] [Full Text] [Related]
49. Two-year clinical outcomes of zotarolimus- and everolimus-eluting durable-polymer-coated stents versus biolimus-eluting biodegradable-polymer-coated stent in patients with acute myocardial infarction with dyslipidemia after percutaneous coronary intervention: data from the KAMIR.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Shin DH; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Heart Vessels; 2019 Feb; 34(2):237-250. PubMed ID: 30167772
[TBL] [Abstract][Full Text] [Related]
50. Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation: The ULTIMATE Trial.
Zhang J; Gao X; Kan J; Ge Z; Han L; Lu S; Tian N; Lin S; Lu Q; Wu X; Li Q; Liu Z; Chen Y; Qian X; Wang J; Chai D; Chen C; Li X; Gogas BD; Pan T; Shan S; Ye F; Chen SL
J Am Coll Cardiol; 2018 Dec; 72(24):3126-3137. PubMed ID: 30261237
[TBL] [Abstract][Full Text] [Related]
51. Impact of renin-angiotensin system inhibitors on long-term clinical outcomes in patients with acute myocardial infarction treated with successful percutaneous coronary intervention with drug-eluting stents: Comparison between STEMI and NSTEMI.
Kim YH; Her AY; Jeong MH; Kim BK; Lee SY; Hong SJ; Shin DH; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Atherosclerosis; 2019 Jan; 280():166-173. PubMed ID: 30529829
[TBL] [Abstract][Full Text] [Related]
52. Impact of everolimus-eluting stent length on long-term clinical outcomes of percutaneous coronary intervention.
Yano H; Horinaka S; Ishimitsu T
J Cardiol; 2018 May; 71(5):444-451. PubMed ID: 29174595
[TBL] [Abstract][Full Text] [Related]
53. Five-year outcomes for first generation drug-eluting stents versus bare-metal stents in patients with ST-segment elevation myocardial infarction: a meta-analysis of randomised controlled trials.
Zheng F; Xing S; Gong Z; Xing Q
Heart Lung Circ; 2014 Jun; 23(6):542-8. PubMed ID: 24529648
[TBL] [Abstract][Full Text] [Related]
54. Intravascular ultrasound-guided vs angiography-guided drug-eluting stent implantation in complex coronary lesions: Meta-analysis of randomized trials.
Bavishi C; Sardar P; Chatterjee S; Khan AR; Shah A; Ather S; Lemos PA; Moreno P; Stone GW
Am Heart J; 2017 Mar; 185():26-34. PubMed ID: 28267472
[TBL] [Abstract][Full Text] [Related]
55. Intravascular Ultrasound-Guided versus Angiography-Guided Percutaneous Coronary Intervention for Stent Thrombosis Elevation Myocardial Infarction: An Updated Systematic Review and Meta-Analysis.
Kalsi J; Suffredini JM; Koh S; Liu J; Khalid MU; Denktas A; Alam M; Kayani W; Jia X
Cardiology; 2024; 149(3):196-204. PubMed ID: 38350431
[TBL] [Abstract][Full Text] [Related]
56. Comparison Between Beta-Blockers with Angiotensin-Converting Enzyme Inhibitors and Beta-Blockers with Angiotensin II Type I Receptor Blockers in ST-Segment Elevation Myocardial Infarction After Successful Percutaneous Coronary Intervention with Drug-Eluting Stents.
Kim YH; Her AY; Jeong MH; Kim BK; Lee SY; Hong SJ; Shin DH; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Cardiovasc Drugs Ther; 2019 Feb; 33(1):55-67. PubMed ID: 30632033
[TBL] [Abstract][Full Text] [Related]
57. Benefits of drug-eluting stents as compared to bare metal stent in ST-segment elevation myocardial infarction: four year results of the PaclitAxel or Sirolimus-Eluting stent vs bare metal stent in primary angiOplasty (PASEO) randomized trial.
Di Lorenzo E; Sauro R; Varricchio A; Capasso M; Lanzillo T; Manganelli F; Mariello C; Siano F; Pagliuca MR; Stanco G; Rosato G; De Luca G
Am Heart J; 2009 Oct; 158(4):e43-50. PubMed ID: 19781402
[TBL] [Abstract][Full Text] [Related]
58. Comparison of six-month outcomes for primary percutaneous revascularization for acute myocardial infarction with drug-eluting versus bare metal stents (from the APEX-AMI study).
Patel MR; Pfisterer ME; Betriu A; Widmisky P; Holmes DR; O'Neill WW; Stebbins A; Van de Werf F; Armstrong PW; Granger CB;
Am J Cardiol; 2009 Jan; 103(2):181-6. PubMed ID: 19121433
[TBL] [Abstract][Full Text] [Related]
59. Long-term results of the randomized comparison of everolimus-eluting stents and sirolimus-eluting stent in patients with ST elevation myocardial infarction (RACES-MI trial).
Di Lorenzo E; Sauro R; Capasso M; Lanni F; Lanzillo T; Carbone G; Manganelli F; Palmieri V; Serino V; Pagliuca MR; Rosato G; Suryapranata H; De Luca G
Int J Cardiol; 2016 Jan; 202():177-82. PubMed ID: 26397405
[TBL] [Abstract][Full Text] [Related]
60. New generation drug-eluting stents for ST-elevation myocardial infarction: a new paradigm for safety.
Garg A; Brodie BR; Stuckey TD; Garberich RF; Tobbia P; Hansen C; Kissling G; Kadakia H; Lips D; Henry TD
Catheter Cardiovasc Interv; 2014 Nov; 84(6):955-62. PubMed ID: 24174334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
